Hypertrophy in the denervated heart: a comparison of central sympatholytic treatment with 6-hydroxydopamine and peripheral sympathectomy with nerve growth factor antiserum.
D000818:Animals; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000378:metabolism; D006332:Cardiomegaly / Q000188:drug therapy*; D002395:Catecholamines / Q000097:blood; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006892:Hydroxydopamines / Q000627:therapeutic use*; D007116:Immunization, Passive; D008297:Male; D009206:Myocardium / Q000378:metabolism; D009414:Nerve Growth Factors / Q000276:immunology*; D051381:Rats; D012083:Renin / Q000097:blood; D013116:Spinal Cord / Q000378:metabolism; D013154:Spleen / Q000378:metabolism; D013562:Sympathectomy; D013565:Sympatholytics / Q000627:therapeutic use*; D014655:Vascular Resistance / Q000187:drug effects
D002395:Catecholamines; D006892:Hydroxydopamines; D009414:Nerve Growth Factors; D013565:Sympatholytics; D012083:Renin